Plasma n-3 fatty acid response to an n-3 fatty acid supplement is modulated by apoE 4 but not by the common PPAR- L162V polymorphism in men

British Journal of Nutrition

Volumn 102, Issue 8, 2009, Pages 1121-1124

  Plourde, Mélanie ^a,b   Vohl, Marie Claude ^b,c   Vandal, Milène ^a,b   Couture, Patrick ^b,c   Lemieux, Simone ^b   Cunnane, Stephen C ^a,b  

^a UNIVERSITÉ DE SHERBROOKE   (Canada)

^b LAVAL UNIVERSITY   (Canada)

^c LAVAL UNIVERSITY   (Canada)

Author keywords

ApoE4; DHA; EPA; PPAR

Indexed keywords

APOLIPOPROTEIN E4; DOCOSAHEXAENOIC ACID; FATTY ACID; ICOSAPENTAENOIC ACID; LEUCINE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; TRIACYLGLYCEROL; VALINE;

ARTICLE; CLINICAL ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; DIET SUPPLEMENTATION; DRUG MECHANISM; FATTY ACID BLOOD LEVEL; FATTY ACID METABOLISM; GENETIC POLYMORPHISM; HETEROZYGOTE; HUMAN; HUMAN CELL; MALE; PRIMARY PREVENTION; TRIACYLGLYCEROL BLOOD LEVEL;

APOLIPOPROTEIN E4; DIETARY SUPPLEMENTS; DOCOSAHEXAENOIC ACIDS; EICOSAPENTAENOIC ACID; FATTY ACIDS, OMEGA-3; HETEROZYGOTE; HUMANS; MALE; POLYMORPHISM, GENETIC; PPAR ALPHA;

EID: 73649133302     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S000711450938215X     Document Type: Article

References (28)

1. Whitehouse PJ, Sciulli CG & Mason RM (1997) Dementia drug development: use of information systems to harmonize global drug development. Psychopharmacol Bull 33, 129-133.
2. Boudrault C, Bazinet RP & Ma DW (2009) Experimental models and mechanisms underlying the protective effects of n-3 polyunsaturated fatty acids in Alzheimer's disease. J Nutr Biochem 20, 1-10.
3. Cunnane SC, Plourde M, Pifferi F, et al. (2009) Fish, docosahexaenoic acid and Alzheimer's disease. Prog Lipid Res (epublication ahead of print version 10 April 2009).
4. Fotuhi M, Mohassel P & Yaffe K (2009) Fish consumption, long-chain omega-3 fatty acids and risk of cognitive decline or Alzheimer disease: a complex association. Nat Clin Pract Neurol 5, 140-152.
5. Plourde M, Fortier M, Vandal M, et al. (2007) Unresolved issues in the link between docosahexaenoic acid and Alzheimer disease. Prostaglandins Leukot Essent Fatty Acids 77, 301-308.
6. Whalley LJ, Fox HC, Wahle KW, et al. (2004) Cognitive aging, childhood intelligence, and the use of food supplements: possible involvement of n-3 fatty acids. Am J Clin Nutr 80, 1650-1657.
7. Arterburn LM, Hall EB & Oken H (2006) Distribution, interconversion, and dose response of n-3 fatty acids in humans. Am J Clin Nutr 83, 1467S-1476S.
8. Vidgren HM, Agren JJ, Schwab U, et al. (1997) Incorporation of n-3 fatty acids into plasma lipid fractions, and erythrocyte membranes and platelets during dietary supplementation with fish, fish oil, and docosahexaenoic acid-rich oil among healthy young men. Lipids 32, 697-705.
9. Balk EM, Lichtenstein AH, Chung M, et al. (2006) Effects of omega-3 fatty acids on serum markers of cardiovascular disease risk: a systematic review. Atherosclerosis 189, 19-30. (Pubitemid 44468073)
10. Panza F,D'IntronoA,Colacicco AM, et al. (2006) Lipidmetabolism in cognitive decline and dementia. Brain Res Rev 51, 275-292.
11. Tai ES, Corella D, Demissie S, et al. (2005) Polyunsaturated fatty acids interact with the PPARA-L162V polymorphism to affect plasma triglyceride and apolipoprotein C-III concentrations in the Framingham Heart Study. J Nutr 135, 397-403.
12. Brune S, Kolsch H, Ptok U, et al. (2003) Polymorphism in the peroxisome proliferator-activated receptor a gene influences the risk for Alzheimer's disease. J Neural Transm 110, 1041-1050.
13. Coon KD, Myers AJ, Craig DW, et al. (2007) A high-density whole-genome association study reveals that APOE is the major susceptibility gene for sporadic late-onset Alzheimer's disease. J Clin Psychiatry 68, 613-618.
14. Huang TL, Zandi PP, Tucker KL, et al. (2005) Benefits of fatty fish on dementia risk are stronger for those without APOE 14. Neurology 65, 1409-1414.
15. Whalley LJ, Deary IJ, Starr JM, et al. (2008) n-3 Fatty acid erythrocyte membrane content, APOE 14, and cognitive variation: an observational follow-up study in late adulthood. Am J Clin Nutr 87, 449-454.
16. Barberger-Gateau P, Raffaitin C, Letenneur L, et al. (2007) Dietary patterns and risk of dementia: the Three-City cohort study. Neurology 69, 1921-1930.
17. Caron-Dorval D, Paquet P, Paradis AM, et al. (2008) Effect of the PPAR-a L162V polymorphism on the cardiovascular disease risk factor in response to n-3 PUFA. J Nutrigenet Nutrigenomic 1, 205-212.
18. Plourde M, Tremblay-Mercier J, Fortier M, et al. (2009) Eicosapentaenoic acid decreases postprandial b-hydroxybutyrate and free fatty acid responses in healthy young and elderly. Nutrition 25, 289-294.
19. Vohl MC, Lepage P, Gaudet D, et al. (2000) Molecular scanning of the human PPARa gene: association of the L162V mutation with hyperapobetalipoproteinemia. J Lipid Res 41, 945-952.
20. Hixson JE & Vernier DT (1990) Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J Lipid Res 31, 545-548.
21. Tassoni D, Kaur G, Weisinger RS, et al. (2008) The role of eicosanoids in the brain. Asia Pac J Clin Nutr 17, 220-228.
22. Kasim-Karakas SE (1995) Impact of n-3 fatty acids on lipoprotein metabolism. Curr Opin Lipidol 6, 167-171.
23. Brossard N, Croset M, Pachiaudi C, et al. (1996) Retroconversion and metabolism of [13C]22:6n-3 in humans and rats after intake of a single dose of [13C]22:6n-3-triacylglycerols. Am J Clin Nutr 64, 577-586.
24. Anil E (2007) The impact of EPA and DHA on blood lipids and lipoprotein metabolism: influence of apoE genotype. Proc Nutr Soc 66, 60-68.
25. Laurin D, Verreault R, Lindsay J, et al. (2003) Omega-3 fatty acids and risk of cognitive impairment and dementia. J Alzheimers Dis 5, 315-322.
26. Caslake MJ, Miles EA, Kofler BM, et al. (2008) Effect of sex and genotype on cardiovascular biomarker response to fish oils: the FINGEN Study. Am J Clin Nutr 88, 618-629.
27. Erkkila AT, Sarkkinen ES, Lindi V, et al. (2001) APOE polymorphism and the hypertriglyceridemic effect of dietary sucrose. Am J Clin Nutr 73, 746-752.
28. Zuijdgeest-van Leeuwen SD, Dagnelie PC, Rietveld T, et al. (1999) Incorporation and washout of orally administered n-3 fatty acid ethyl esters in different plasma lipid fractions. Br J Nutr 82, 481-488.